Literature DB >> 12956848

Adenocarcinoma of the uterine cervix: the presence of human papillomavirus and the method of detection.

Sonia Andersson1, Barbro Larson, Anders Hjerpe, Claes Silfverswärd, Jan Sällström, Erik Wilander, Eva Rylander.   

Abstract

BACKGROUND: Effective screening programs have contributed to a decrease in the incidence of cervical squamous cell carcinomas but have had a limited sensitivity in the detection of adenocarcinoma precursor lesions. The aim of our study was to analyze cervical adenocarcinoma in greater detail: symptoms preceding the detection, the method of detection and the prevalence of human papillomavirus (HPV) with respect to age at diagnosis.
MATERIAL AND METHODS: Clinical data were abstracted from the medical records of 82 women with pure invasive cervical adenocarcinomas. As diagnostic tools we used polymerase chain reaction (PCR)-based single-strand conformation polymorphism (SSCP) and/or direct DNA sequencing for HPV detection.
RESULTS: Age at diagnosis predicting factors were HPV status, positive lymph nodes, histology and stage. HPV-negativity, lymph node metastases, advanced stage and poor differentiation were all associated with a high diagnostic age. In the multivariate analysis only HPV status was shown to have an independent impact on age at diagnosis, while stage showed only borderline significance. Twenty-three percent of the cancers were detected by screening and the remaining were due to different symptoms. Among the women considered, 93% had a normal Papanicolaou (Pap) smear 3 years before diagnosis and 60% within 1 year. There was no significant correlation between smoking, oral contraceptives and HPV-positivity.
CONCLUSIONS: The absence of HPV was significantly associated with a high age at diagnosis. Pap screening had a limited effect in detecting adenocarcinoma at an early stage.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12956848     DOI: 10.1034/j.1600-0412.2003.00263.x

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  8 in total

1.  Expression of Ki-67 and squamous intraepithelial lesions are related with HPV in endocervical adenocarcinoma.

Authors:  Eduardo Cambruzzi; Cláudio Galleano Zettler; Cláudio Osmar Pereira Alexandre
Journal:  Pathol Oncol Res       Date:  2005-07-01       Impact factor: 3.201

2.  Expression of the p53 target Wig-1 is associated with HPV status and patient survival in cervical carcinoma.

Authors:  Li-Di Xu; Susanne Muller; Srinivasan R Thoppe; Fredrik Hellborg; Lena Kanter; Mikael Lerner; Biying Zheng; Svetlana Bajalica Lagercrantz; Dan Grandér; Keng Ling Wallin; Klas G Wiman; Catharina Larsson; Sonia Andersson
Journal:  PLoS One       Date:  2014-11-07       Impact factor: 3.240

3.  The economic burden of human papillomavirus-related precancers and cancers in Sweden.

Authors:  Ellinor Östensson; Maria Silfverschiöld; Lennart Greiff; Christine Asciutto; Johan Wennerberg; Marie-Louise Lydrup; Ulf Håkansson; Pär Sparén; Christer Borgfeldt
Journal:  PLoS One       Date:  2017-06-26       Impact factor: 3.240

4.  Self-sampling for high-risk human papillomavirus as a follow-up alternative after treatment of high-grade cervical intraepithelial neoplasia.

Authors:  Ellinor Östensson; Karen Belkić; Torbjörn Ramqvist; Miriam Mints; Sonia Andersson
Journal:  Oncol Lett       Date:  2021-01-31       Impact factor: 2.967

5.  Predictors of treatment failure for adenocarcinoma in situ of the uterine cervix: Up to 14 years of recorded follow-up.

Authors:  Karen Belkić; Sonia Andersson; Susanna Alder; Miriam Mints; David Megyessi
Journal:  Oncol Lett       Date:  2022-08-25       Impact factor: 3.111

Review 6.  HPV-Negative Cervical Cancer: A Narrative Review.

Authors:  Francesca Arezzo; Gennaro Cormio; Vera Loizzi; Gerardo Cazzato; Viviana Cataldo; Claudio Lombardi; Giuseppe Ingravallo; Leonardo Resta; Ettore Cicinelli
Journal:  Diagnostics (Basel)       Date:  2021-05-26

7.  Human papillomavirus 'reflex' testing as a screening method in cases of minor cytological abnormalities.

Authors:  M Fröberg; B Johansson; A Hjerpe; S Andersson
Journal:  Br J Cancer       Date:  2008-08-19       Impact factor: 7.640

8.  Frequent gain of the human telomerase gene TERC at 3q26 in cervical adenocarcinomas.

Authors:  S Andersson; K-L Wallin; A-C Hellström; L E Morrison; A Hjerpe; G Auer; T Ried; C Larsson; K Heselmeyer-Haddad
Journal:  Br J Cancer       Date:  2006-07-18       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.